← Eichor
Condition: Gastrointestinal Intolerance Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gastrointestinal Intolerance

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study of CS0159 in Patients With PBC With Inadequate Response or Intolerance to UDCA
Phase 3 · 42 location(s) · Cascade Pharmaceuticals, Inc · NCT07282353Auricular Vagal Nerve Stimulation for Hypermobile Ehlers-Danlos Syndrome
NA · 1 location(s) · Medical College of Wisconsin · NCT05212129The PODIUM Study - a Three-arm Comparison of Target Therapies After Anti-TNFα in Ulcerative Colitis
Phase N/A · 1 location(s) · Humanitas Clinical and Research Center · NCT06691061Predictive Value of Gastrointestinal Blood Flow for Enteral Nutrition Intolerance in Critically Ill Patients
Phase N/A · 1 location(s) · Ruijin Hospital · NCT07521111Milk for Diabetes Prevention
NA · 1 location(s) · Albert Einstein College of Medicine · NCT06513026Brachyspira and Intestinal Allergy-like Immune Reactions in Patients With Irritable Bowel Syndrome (IBS)
NA · 1 location(s) · Magnus Simrén · NCT06413004A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard
Phase 2 · 1 location(s) · Shanghai Henlius Biotech · NCT06769113GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance
Phase 2 · 2 location(s) · University of Pennsylvania · NCT04731272Transcutaneous Spinal Cord Stimulation Home Study
NA · 1 location(s) · Michael Berger · NCT06838637Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer
Phase 1/Phase 2 · 5 location(s) · STCube, Inc. · NCT06873763Preventing Gastrointestinal Disturbance in Patients After Longitudinal Laparotomy.
Phase 2 · 3 location(s) · Orexa BV · NCT05923086Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Phase N/A · 1 location(s) · Brain Inflammation Collaborative · NCT04806620Combined Lactulose H2-breath Test With Abdominal Imaging
Phase N/A · 1 location(s) · Klinik Arlesheim · NCT07145580Effect of Blenderized Enteral Tube Feeds on Pediatric Upper Gastrointestinal Tract Physiology
NA · 1 location(s) · Boston Children's Hospital · NCT04900597Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance
NA · 1 location(s) · Andrea Charvet · NCT06609213Gastrointestinal Dysfunction in Aortic Surgery Patients
Phase N/A · 1 location(s) · Instituto Nacional de Cardiologia Ignacio Chavez · NCT06514170Goat vs. Cow Milk Digestive Tolerance
NA · 1 location(s) · Institut National de Recherche pour l'Agriculture, l'Aliment · NCT07239856Proper Dietary Management, Follow-up, and Lactase Enzyme Supplementation for Lactose Intolerance
Phase N/A · 1 location(s) · European Institute of Oncology · NCT06773650ImpACt of Very High Protein Content Enteral nUtrition Formulas on Critically Ill MUltipLe trAuma paTiEnts
Phase N/A · 1 location(s) · Romanian Society for Enteral and Parenteral Nutrition · NCT05647135Crohn's Disease: Efficacy, Safety, and Pharmacokinetics of Upadacitinib in Pediatric Subjects With Moderately to Severel
Phase 3 · 85 location(s) · AbbVie · NCT06332534A Registry for the Food Allergy Community
Phase N/A · 1 location(s) · Food Allergy Research & Education · NCT04653324A Phase II Clinical Study to Evaluate HLX43 in Patients With Locally Advanced or Metastatic HCC Failed or Intolerance to
Phase 2 · 1 location(s) · Shanghai Henlius Biotech · NCT06742892Total Underwater Colonoscopy (TUC) for Improved Colorectal Cancer Screening: A Randomized Controlled Trial
NA · 5 location(s) · Vestre Viken Hospital Trust · NCT06333392Fecal Microbiota Transplantation for Irritable Bowel Syndrome Associated Food Intolerance
NA · 1 location(s) · Helsinki University Central Hospital · NCT05361785A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
Phase 1 · 1 location(s) · Nielsen Fernandez-Becker · NCT07377565Lactobreath: A Study to Diagnose Lactose Intolerance Using Breath Markers
NA · 1 location(s) · ETH Zurich · NCT06177938Effect of Semi-elemental Enteral Nutrition on Gastrointestinal Tolerance in Patients With Traumatic Brain Injury.
NA · 1 location(s) · Tang-Du Hospital · NCT07092423
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.